Science stock
Private-market facts for current and former Science employees researching their stock.
Overview
Technology studio and venture fund that creates, invests in, and acquires companies across consumer products and direct-to-consumer brands including Dollar Shave Club.
Science outlook
For employees evaluating Science equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Science shares
Why shareholders consider selling
Shareholders in Science may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Science does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Science stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Blockchain & Web3 sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Science shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Science shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Blockchain & Web3 market conditions, and any recent private-market transaction activity. Data points such as its reported $2B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Science shareholders
Exploring equity in Science often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Science's latest funding details have not been publicly disclosed.
Founders & company background
Science was founded in 2011 by Michael Jones, Peter Pham, Tom Dare, Greg Gilmore and is headquartered in Santa Monica, CA.
Industry
Similar private companies
Latest Science news
Frequently asked questions
- Is Science still a private company?
- Yes, Science is currently a private company.
- What is Science's latest funding round?
- The latest funding round has not been publicly disclosed.
- What is Science's valuation?
- Science's latest reported valuation is $2B.
- Who are the investors in Science?
- Investor information is not currently available.
- Can I sell my Science stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Science stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Science data compiled from funding disclosures, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.